ALAMEDA, Calif., Oct. 3, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for chronic neurological care, announced today that Chief Business Officer Michael Coffee will present information on Avigen's development programs and product pipeline at the 2007 BIO Investor Forum. Mr. Coffee will present on Wednesday, October 10, 2007, from 12:15 to 12:45 p.m. PDT at the Palace Hotel in San Francisco.
